Tumor-derived mesenchymal progenitor cell-related genes in the regulation of breast cancer proliferation

Background: Breast cancer (BC) is one of the most common malignancies worldwide, and its development is affected in various ways by the tumor microenvironment (TME). Tumor -derived mesenchymal progenitor cells (MPCs), as the most important components of the TME, participate in the proliferation and metastasis of BC in several ways. In this study, we aimed to characterize the genes associated with tumor -derived MPCs and determine their effects on BC cells. Methods: Tumor -derived MPCs and normal breast tissue -derived mesenchymal stem cells (MSCs) were isolated from tissues specimens of patients with BC. We conducted culture and passage, phenotype identification, proliferation and migration detection, inflammatory factor release detection, and other experiments on isolated MPCs from tumors and MSCs from normal breast tissues. Three paired tumorderived MPCs and normal breast tissue -derived MSCs were then subjected to transcriptome analysis to determine the expression profiles of the relevant genes, and quantitative real-time polymerase chain reaction (qRT-PCR) was used to further confirm gene expression. Subsequently, the overexpression plasmids were transfected into tumor -derived MPCs, and the expression of various inflammatory factors of tumor -derived MPCs and their proliferation were characterized with a cell viability test reagent (Cell Counting Kit 8). Subsequently, the transfected tumor -derived MPCs were cocultured with BC cells using a conditioned medium coculture method to clarify the role of tumor -derived MSCs in BC. Results: Tumor -derived MPCs expressed stem cell characteristics including CD105, CD90, and CD73 and exhibited adipogenic and osteogenic differentiation in vitro. The proliferation of tumor -derived MPCs was significantly lower than that of normal breast tissue -derived MSCs, and the invasive metastatic ability was comparable; however, MPCs were found to release inflammatory factors such as interleukin 6 (IL -6) and transforming growth factor f3 (TGF-f3). Transcriptome analysis showed that stomatin ( STOM ), collagen and calcium binding EGF domains 1 ( CCBE1 ), and laminin subunit alpha 5 ( LAMA5 ) were significantly upregulated in tumor -derived MPCs. Among them, STOM was highly expressed in tumor -derived MPCs, which mediated the slow proliferation of MPCs and promoted the proliferation of BC cells. Conclusions: STOM , CCBE1 , and LAMA5 were highly expressed in tumor -derived MPCs, with STOM being found to retard the proliferation of MPCs but promote the proliferation of BC cells. There findings present new possibilities in targeted microenvironmental therapy for BC.